1 |
98% dehydrated alcohol |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
298 [1] 298 💬 |
2 |
A04ad10 |
- |
- |
- |
- |
298 [1] 298 💬 |
3 |
Acetate |
Acetate |
- |
- |
- |
001 [43] 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
4 |
Acetyl-l-carnitine |
Acetylcarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
298 [1] 298 💬 |
5 |
Acetyl-l-carnitine 1000mg 2x per day for 3 months |
Acetylcarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
298 [1] 298 💬 |
6 |
Acetylcysteine |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
006 [16] 6 , 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬 |
7 |
Alanine |
Alanine |
[1] D00012 D00012 💬 |
- |
- |
006 [4] 6 , 13, 298, 299 💬 |
8 |
Alcohol |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
013 [4] 13, 58, 279, 298 💬 |
9 |
Alpha 1-antitrypsin |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 [2] 231, 298 💬 |
10 |
Amino acids |
Amino acids |
- |
- |
- |
070 [3] 70, 240, 298 💬 |
11 |
Amlodipine |
Amlodipine |
[3] D00615 D00615, D02914 D02914, D07450 D07450 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [3] 51, 67, 298 💬 |
12 |
Amlodipine (drug) |
Amlodipine |
[3] D00615 D00615, D02914 D02914, D07450 D07450 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
298 [1] 298 💬 |
13 |
Analgesics |
- |
- |
- |
- |
298 [1] 298 💬 |
14 |
Antioxidant plus pregabalin |
Pregabalin |
[1] D02716 D02716 💬 |
CACNA2D1 [4] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes [7] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
298 [1] 298 💬 |
15 |
Antioxidants |
- |
- |
- |
- |
090 [3] 90, 298, 310 💬 |
16 |
Antox |
- |
- |
- |
- |
298 [1] 298 💬 |
17 |
Antox (vers) 1.2 |
- |
- |
- |
- |
298 [1] 298 💬 |
18 |
Antox (vers.)1.2 |
- |
- |
- |
- |
298 [1] 298 💬 |
19 |
Antox version 1.2 |
- |
- |
- |
- |
298 [1] 298 💬 |
20 |
Ascorbic acid |
Ascorbic acid |
[1] D00018 D00018 💬 |
- |
- |
010 [4] 10, 97, 206, 298 💬 |
21 |
Autologous mesenchymal stromal cell |
- |
- |
- |
- |
096 [2] 96, 298 💬 |
22 |
Behavioral: smoking and alcohol assumption |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
298 [1] 298 💬 |
23 |
Benzoyl-l-tyrosyl-[1-13c]alanine (bz-tyr-ala) |
Alanine |
[1] D00012 D00012 💬 |
- |
- |
298 [1] 298 💬 |
24 |
Bupivacaine |
Bupivacaine |
[2] D01450 D01450, D07552 D07552 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
046 [8] 46, 51, 53, 70, 96, 168, 226, 298 💬 |
25 |
Bupivicaine alone |
- |
- |
- |
- |
298 [1] 298 💬 |
26 |
Calcium |
Calcium |
- |
- |
- |
006 [27] 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
27 |
Calcium, dietary |
Calcium |
- |
- |
- |
298 [1] 298 💬 |
28 |
Carbon |
Activated charcoal |
[1] D03251 D03251 💬 |
- |
- |
006 [9] 6 , 46, 50, 51, 85, 86, 96, 97, 298 💬 |
29 |
Carbon monoxide |
Activated charcoal |
[2] D03251 D03251, D09706 D09706 💬 |
- |
- |
085 [3] 85, 86, 298 💬 |
30 |
Carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 [8] 5 , 13, 58, 96, 97, 265, 298, 316 💬 |
31 |
Cholecalciferol |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 [9] 13, 19, 34, 46, 49, 96, 97, 298, 299 💬 |
32 |
Creon |
- |
- |
- |
- |
298 [2] 298, 299 💬 |
33 |
Creon 10000 |
- |
- |
- |
- |
298 [2] 298, 299 💬 |
34 |
Creon 25000 |
- |
- |
- |
- |
298 [2] 298, 299 💬 |
35 |
Creon36™ |
- |
- |
- |
- |
298 [1] 298 💬 |
36 |
Device: mayo interactive breath hold monitor |
Methamidophos |
- |
- |
- |
298 [2] 298, 300 💬 |
37 |
Diagnostic test: genetic sequencing |
- |
- |
- |
- |
298 [1] 298 💬 |
38 |
Diagnostic test: hemoglobin a1c |
Hemoglobin |
- |
- |
- |
298 [1] 298 💬 |
39 |
Diagnostic test: mixed meal tolerance test |
- |
- |
- |
- |
298 [1] 298 💬 |
40 |
Diagnostic test: other exploratory blood biomarkers |
- |
- |
- |
- |
298 [1] 298 💬 |
41 |
Diazepam |
Diazepam |
[1] D00293 D00293 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
046 [3] 46, 155, 298 💬 |
42 |
Dronabinol |
Dronabinol |
[1] D00306 D00306 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
002 [5] 2 , 13, 46, 271, 298 💬 |
43 |
Ensure surgical |
- |
- |
- |
- |
298 [1] 298 💬 |
44 |
Ercp with bupivacaine infusion |
Bupivacaine |
[2] D01450 D01450, D07552 D07552 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
298 [1] 298 💬 |
45 |
Esomeprazole |
Esomeprazole |
[4] D01984 D01984, D04056 D04056, D07917 D07917, D09339 D09339 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
013 [6] 13, 46, 86, 98, 298, 299 💬 |
46 |
Etanercept |
Etanercept |
[1] D00742 D00742 💬 |
LTA [2] LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
015 [14] 15, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬 |
47 |
Eur-1008 (apt-1008) high dose |
- |
- |
- |
- |
298 [1] 298 💬 |
48 |
Eur-1008 (apt-1008) low dose |
- |
- |
- |
- |
298 [1] 298 💬 |
49 |
Eur-1066-a |
- |
- |
- |
- |
298 [1] 298 💬 |
50 |
Eur-1066-b |
- |
- |
- |
- |
298 [1] 298 💬 |
51 |
Eus procedure with drug injection |
- |
- |
- |
- |
298 [1] 298 💬 |
52 |
Fluimucil |
- |
- |
- |
- |
085 [4] 85, 94, 193, 298 💬 |
53 |
Fluimucil*20cpr eff 600mg |
- |
- |
- |
- |
094 [2] 94, 298 💬 |
54 |
Gabapentin |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
006 [5] 6 , 13, 19, 70, 298 💬 |
55 |
Gabapentin prescriptions |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
298 [1] 298 💬 |
56 |
Gold |
Gold |
- |
- |
- |
002 [38] 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
57 |
Helopanflat mono® |
- |
- |
- |
- |
298 [1] 298 💬 |
58 |
Hemoglobin |
Hemoglobin |
- |
- |
- |
298 [1] 298 💬 |
59 |
Human secretin |
Secretin human |
- |
- |
- |
298 [1] 298 💬 |
60 |
Hydroxychloroquine |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
013 [23] 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
61 |
Indomethacin |
Indomethacin |
[3] D00141 D00141, D01565 D01565, D02110 D02110 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
225 [3] 225, 271, 298 💬 |
62 |
Intra plexus triamcinolone and bupivicaine injection |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
298 [1] 298 💬 |
63 |
Kreon 25000 |
- |
- |
- |
- |
298 [2] 298, 299 💬 |
64 |
L-carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
013 [6] 13, 96, 97, 265, 298, 316 💬 |
65 |
Lannacher |
- |
- |
- |
- |
298 [1] 298 💬 |
66 |
Lanreotide |
Lanreotide |
[1] D04666 D04666 💬 |
- |
- |
067 [4] 67, 73, 85, 298 💬 |
67 |
Lanreotide acetate |
Acetate |
[1] D04666 D04666 💬 |
- |
- |
067 [4] 67, 73, 85, 298 💬 |
68 |
Lipase |
- |
- |
- |
- |
298 [2] 298, 299 💬 |
69 |
Liprotamase |
- |
- |
- |
- |
298 [2] 298, 299 💬 |
70 |
Lyrica |
- |
- |
- |
- |
298 [1] 298 💬 |
71 |
Lyrica® |
- |
- |
- |
- |
298 [1] 298 💬 |
72 |
Magnesiocard 2.5mmol |
- |
- |
- |
- |
298 [1] 298 💬 |
73 |
Magnesium |
Magnesium |
- |
- |
- |
006 [16] 6 , 11, 13, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬 |
74 |
Magnesium aspartate |
Magnesium |
[1] D02026 D02026 💬 |
- |
- |
298 [1] 298 💬 |
75 |
Magnesium aspartate hydrochloride |
Magnesium |
[1] D02026 D02026 💬 |
- |
- |
298 [1] 298 💬 |
76 |
Methionine |
Methionine |
[2] D00019 D00019, D04983 D04983 💬 |
- |
- |
034 [7] 34, 75, 84, 93, 229, 298, 300 💬 |
77 |
Mezym f |
- |
- |
- |
- |
298 [1] 298 💬 |
78 |
Midazolam |
Midazolam |
[3] D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
002 [11] 2 , 3 , 6 , 13, 21, 46, 70, 96, 97, 231, 298 💬 |
79 |
Monitor |
Methamidophos |
- |
- |
- |
002 [18] 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
80 |
Ms1819 |
- |
- |
- |
- |
298 [2] 298, 299 💬 |
81 |
Ms1819-sd |
MS-1819 |
- |
- |
- |
298 [2] 298, 299 💬 |
82 |
Multienzymes (lipase, protease etc.) |
- |
- |
- |
- |
298 [2] 298, 299 💬 |
83 |
Namisol |
- |
- |
- |
- |
013 [2] 13, 298 💬 |
84 |
Nexium (esomeprazole magnesium) |
Esomeprazole |
[4] D01984 D01984, D04056 D04056, D07917 D07917, D09339 D09339 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
298 [1] 298 💬 |
85 |
Ni-03 |
- |
- |
- |
- |
298 [1] 298 💬 |
86 |
Omeprazole |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 [16] 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
87 |
Other: carbon monoxide-bubbled mediums |
Activated charcoal |
[2] D03251 D03251, D09706 D09706 💬 |
- |
- |
298 [1] 298 💬 |
88 |
Other: eus procedure |
- |
- |
- |
- |
298 [1] 298 💬 |
89 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 [21] 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
90 |
Other: low-intensity exercise therapy |
- |
- |
- |
- |
298 [1] 298 💬 |
91 |
Other: no enzyme therapy |
- |
- |
- |
- |
298 [1] 298 💬 |
92 |
Other: nutrition counseling |
- |
- |
- |
- |
298 [1] 298 💬 |
93 |
Other: quality-of-life assessment |
- |
- |
- |
- |
034 [5] 34, 36, 51, 96, 298 💬 |
94 |
Other: questionnaire administration |
- |
- |
- |
- |
016 [4] 16, 34, 51, 298 💬 |
95 |
Oxycodone |
Oxycodone |
[3] D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [7] 6 , 13, 46, 70, 226, 231, 298 💬 |
96 |
Oxycodone depot ”sandoz”, depot tablets |
Oxycodone |
[3] D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
298 [1] 298 💬 |
97 |
Oxycodone hydrochloride |
Oxycodone |
[3] D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [4] 6 , 70, 226, 298 💬 |
98 |
Oxycodonhydrochlorid ”lannacher”, depot tablets |
- |
- |
- |
- |
298 [1] 298 💬 |
99 |
Oxynorm |
- |
- |
- |
- |
298 [1] 298 💬 |
100 |
Pancreatic enzymes |
- |
- |
- |
- |
298 [1] 298 💬 |
101 |
Pancreatin |
Pancrelipase |
[1] D05349 D05349 💬 |
- |
- |
298 [2] 298, 299 💬 |
102 |
Pancrelipase |
Pancrelipase |
[1] D05349 D05349 💬 |
- |
- |
298 [2] 298, 299 💬 |
103 |
Pancrelipase delayed release capsule |
Pancrelipase |
[1] D05349 D05349 💬 |
- |
- |
298 [2] 298, 299 💬 |
104 |
Pancrelipase/pancreas powder |
Pancrelipase |
[1] D05349 D05349 💬 |
- |
- |
298 [2] 298, 299 💬 |
105 |
Panzytrat |
- |
- |
- |
- |
298 [1] 298 💬 |
106 |
Panzytrat 25.000 |
- |
- |
- |
- |
298 [1] 298 💬 |
107 |
Panzytrat 25.000 fip-e units of lipase |
- |
- |
- |
- |
298 [1] 298 💬 |
108 |
Pentoxifylline |
Pentoxifylline |
[1] D00501 D00501 💬 |
- |
- |
026 [10] 26, 56, 84, 93, 96, 113, 220, 222, 296, 298 💬 |
109 |
Perflubutane |
Perflubutane |
[1] D05440 D05440 💬 |
- |
- |
298 [2] 298, 300 💬 |
110 |
Pfd |
- |
- |
- |
- |
051 [2] 51, 298 💬 |
111 |
Pioglitazone |
Pioglitazone |
[2] D00945 D00945, D08378 D08378 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
112 |
Pl 00512/0150 |
- |
- |
- |
- |
298 [1] 298 💬 |
113 |
Pregabalin |
Pregabalin |
[1] D02716 D02716 💬 |
CACNA2D1 [4] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes [7] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
013 [5] 13, 36, 46, 70, 298 💬 |
114 |
Procedure: celiac block with triamcinolone and bupivicaine |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
298 [1] 298 💬 |
115 |
Procedure: endoscopic drainage of the main pancreatic duct |
- |
- |
- |
- |
298 [1] 298 💬 |
116 |
Procedure: extracorporeal shock wave lithotripsy |
- |
- |
- |
- |
298 [1] 298 💬 |
117 |
Procedure: no celiac block |
- |
- |
- |
- |
298 [1] 298 💬 |
118 |
Prolastin |
- |
- |
- |
- |
231 [3] 231, 298, 299 💬 |
119 |
Prolastin-c |
- |
- |
- |
- |
231 [2] 231, 298 💬 |
120 |
Proton pump inhibitor (ppi) |
- |
- |
- |
- |
298 [1] 298 💬 |
121 |
Radiation: uv-filtered light. |
- |
- |
- |
- |
298 [1] 298 💬 |
122 |
Radiation: uvb |
- |
- |
- |
- |
298 [1] 298 💬 |
123 |
Recombinant microbial lipase |
- |
- |
- |
- |
298 [1] 298 💬 |
124 |
Recombinant microbial lipase slv339 |
- |
- |
- |
- |
298 [1] 298 💬 |
125 |
Regn475/sar164877 |
- |
- |
- |
- |
298 [1] 298 💬 |
126 |
Reparixin |
Reparixin |
[1] D08984 D08984 💬 |
CXCR1 [2] CXCR1, CXCR2 💬 |
Chemokine signaling pathway [7] Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, Human cytomegalovirus infection, Phospholipase D signaling pathway, Viral protein interaction with cytokine and cytokine receptor |
298 [2] 298, 299 💬 |
127 |
Rg1068 (synthetic human secretin) |
Secretin human |
- |
- |
- |
298 [1] 298 💬 |
128 |
Rvg 13760 |
- |
- |
- |
- |
298 [1] 298 💬 |
129 |
S-ketamin |
- |
- |
- |
- |
298 [1] 298 💬 |
130 |
Sa |
- |
- |
- |
- |
006 [5] 6 , 30, 60, 118, 298 💬 |
131 |
Sa-001 |
- |
- |
- |
- |
298 [1] 298 💬 |
132 |
Secretin |
Secretin human |
- |
- |
- |
298 [1] 298 💬 |
133 |
Selenium |
Selenium |
- |
- |
- |
013 [3] 13, 278, 298 💬 |
134 |
Simvastatin |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [21] 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
135 |
Slv339 |
- |
- |
- |
- |
298 [1] 298 💬 |
136 |
Somatuline |
- |
- |
- |
- |
067 [2] 67, 298 💬 |
137 |
Somatuline autogel 90 mg |
- |
- |
- |
- |
298 [1] 298 💬 |
138 |
Soy bread |
- |
- |
- |
- |
298 [1] 298 💬 |
139 |
Synthetic human secretin |
Secretin human |
- |
- |
- |
298 [1] 298 💬 |
140 |
Tanezumab |
Tanezumab |
[1] D09387 D09387 💬 |
NGF [1] NGF 💬 |
Apoptosis [9] Apoptosis, Calcium signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
226 [2] 226, 298 💬 |
141 |
Tetrahydro-6,6,9-tri methyl-3-penthyl-6 h-dibenzo[ b,d ]pyran-1-ol |
- |
- |
- |
- |
298 [1] 298 💬 |
142 |
Tetrahydrocannabinol |
Dronabinol |
[1] D00306 D00306 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
008 [3] 8 , 13, 298 💬 |
143 |
Thalidomide |
Thalidomide |
[1] D00754 D00754 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
002 [20] 2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬 |
144 |
Tocopherol |
Tocopherol |
[1] D02332 D02332 💬 |
- |
- |
013 [5] 13, 49, 206, 257, 298 💬 |
145 |
Triamcinolone |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [8] 35, 46, 56, 70, 90, 96, 226, 298 💬 |
146 |
Tyr |
- |
- |
- |
- |
075 [2] 75, 298 💬 |
147 |
Viokase 16 |
- |
- |
- |
- |
298 [1] 298 💬 |
148 |
Viokase 16 (pancrelipase) + nexium |
Pancrelipase |
[1] D05349 D05349 💬 |
- |
- |
298 [1] 298 💬 |
149 |
Viokase® 16 |
- |
- |
- |
- |
298 [1] 298 💬 |
150 |
Vitamin d |
Vitamin D |
- |
- |
- |
013 [21] 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 274, 298, 299 💬 |
151 |
Vitamin d 100ug |
Vitamin D |
- |
- |
- |
298 [1] 298 💬 |
152 |
Vitamin d 10ug |
Vitamin D |
- |
- |
- |
298 [1] 298 💬 |
153 |
Yarrowia lipolytica lipase |
- |
- |
- |
- |
298 [1] 298 💬 |
154 |
Zenpep |
- |
- |
- |
- |
298 [2] 298, 299 💬 |
155 |
Zentase |
- |
- |
- |
- |
298 [1] 298 💬 |